We restricted the analysis to RTK I, RTK II, MES, Midline, and MYCN18 tumors and found 500 differentially methylated CpGs compared to >10 000 differential CpGs in the unrestricted analysis underling the effect of the glioma classification over TERT mutation. This evidence concerns the gene TERT and central nervous system cancer.